BioCentury | Dec 19, 2005
Strategy

Cyclacel funding history

...BioVentures; Invesco; Lloyds Development Capital; GeneChem Management; Merifin Capital; Merlin Biosciences; Noble Grossart; Northern Ventures; Quester Capital...
BioCentury | Sep 27, 2004
Emerging Company Profile

Corporate Profile

...Venture Fund; Global Life Science Ventures; Gilde Investment Management; Deutsche Venture Capital; ABN AMRO Capital; Quester Capital...
BioCentury | Nov 26, 2003
Financial News

Glycart raises CHF 18M

...Ventures and Gilde Investment Management. Other investors included DVC Deutsche Venture Capital; ABN AMRO Capital; Quester Capital...
BioCentury | Nov 17, 2003
Finance

Ebb & Flow

...the spring to raise £15 million ($25 million). Other investors include Abingworth; JP Morgan Partners; Quester Capital...
BioCentury | Nov 17, 2003
Financial News

Lorantis raises L25M

...Partners. Other investors in the preclinical allergy and autoimmune company included Abingworth; JP Morgan Partners; Quester Capital...
BioCentury | Apr 21, 2003
Finance

Ebb & Flow

...company Oxxon Pharmaccines raised £15 million ($23.4 million) in a series B round led by Quester Capital...
BioCentury | Apr 14, 2003
Financial News

Oxxon raises L15 million

...Pharmaccines (Oxford, U.K.) raised L15 million ($23.4 million) in a series B round led by Quester Capital...
BioCentury | Sep 16, 2002
Finance

Ebb & Flow

...raised £11.5 million ($17.9 million) in a private round led by Advent Venture Partners and Quester Capital...
BioCentury | Sep 10, 2002
Financial News

Avidex raises L11.5 million

...raised L11.5 million ($17.9 million) in a private round led by Advent Venture Partners and Quester Capital...
BioCentury | Jun 25, 2001
Finance

Ebb & Flow

...61.6% of Celmed. In the U.K., Johnson & Johnson Development joined Avlar BioVentures; 3i; and Quester Capital...
Items per page:
1 - 10 of 16
BioCentury | Dec 19, 2005
Strategy

Cyclacel funding history

...BioVentures; Invesco; Lloyds Development Capital; GeneChem Management; Merifin Capital; Merlin Biosciences; Noble Grossart; Northern Ventures; Quester Capital...
BioCentury | Sep 27, 2004
Emerging Company Profile

Corporate Profile

...Venture Fund; Global Life Science Ventures; Gilde Investment Management; Deutsche Venture Capital; ABN AMRO Capital; Quester Capital...
BioCentury | Nov 26, 2003
Financial News

Glycart raises CHF 18M

...Ventures and Gilde Investment Management. Other investors included DVC Deutsche Venture Capital; ABN AMRO Capital; Quester Capital...
BioCentury | Nov 17, 2003
Finance

Ebb & Flow

...the spring to raise £15 million ($25 million). Other investors include Abingworth; JP Morgan Partners; Quester Capital...
BioCentury | Nov 17, 2003
Financial News

Lorantis raises L25M

...Partners. Other investors in the preclinical allergy and autoimmune company included Abingworth; JP Morgan Partners; Quester Capital...
BioCentury | Apr 21, 2003
Finance

Ebb & Flow

...company Oxxon Pharmaccines raised £15 million ($23.4 million) in a series B round led by Quester Capital...
BioCentury | Apr 14, 2003
Financial News

Oxxon raises L15 million

...Pharmaccines (Oxford, U.K.) raised L15 million ($23.4 million) in a series B round led by Quester Capital...
BioCentury | Sep 16, 2002
Finance

Ebb & Flow

...raised £11.5 million ($17.9 million) in a private round led by Advent Venture Partners and Quester Capital...
BioCentury | Sep 10, 2002
Financial News

Avidex raises L11.5 million

...raised L11.5 million ($17.9 million) in a private round led by Advent Venture Partners and Quester Capital...
BioCentury | Jun 25, 2001
Finance

Ebb & Flow

...61.6% of Celmed. In the U.K., Johnson & Johnson Development joined Avlar BioVentures; 3i; and Quester Capital...
Items per page:
1 - 10 of 16